标题 |
MITO16b/MANGO–OV2/ENGOT–ov17 Investigators. Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial
有丝分裂16b/芒果-OV2/ENGOT-OV17研究者。卡铂联合贝伐单抗治疗铂类敏感卵巢癌的疗效比较:一项随机3期试验
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
求助人 | |
下载 |